Practice Point Communications
Claim This Podcastby Practice Point Communications
Podcast Authority
Beta
Podcast Overview
<p>WE'VE MOVED!</p><p>Thank you to all our loyal followers. We want to inform you that we have separated our podcast into specific therapeutic area podcasts to hopefully make it easier for you to find the content you're interested in. We now have podcasts for Hematology, Oncology, Pulmonology, Cardiology, HIV, Immunology and Rare Diseases. Just search on Practice Point CME and follow the podcast of your choice.</p><p>Same great content, just easier to find!</p>
Language
🇺🇲
Publishing Since
5/19/2021
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
BetaRecommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind Practice Point Communications
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
January 20, 2025
Integrating Practice-Changing Updates to Improve Outcomes Among Patients
Please refer to the activity landing page for the downloadable slides.Primary biliary cholangitis (PBC) is a chronic, cholestatic, autoimmune liver disease that can progress to end-stage liver disease. Recent developments have led to important updates in the diagnosis and use of novel approaches in treatment for patients with PBC. This podcast will utilize case-based discussion to address implications of risk stratification and practice-changing evidence for the long-term management among div...
January 9, 2025
Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Secondary HLH/MAS & Updates from ASH
Conversations in IFN-y explores the latest advancements in understanding and managing secondary hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS), with updates from ASH 2024. Featuring discussions by leading experts, the educational activity covers breakthroughs in diagnostic technologies. Topics covered include AI-based histology models and PET/CT imaging, therapeutic innovations such as emapalumab and reduced-intensity conditioning for HSCT. The implications ...
December 19, 2024
What’s New Doc? End of the Year Updates on CAR T-cell Therapy in Multiple Myeloma
Dr. Joseph Mikhael, MD, MEd, FRCPC, FACP, shares the latest updates on CAR T-cell therapy in multiple myeloma, transforming treatment outcomes for patients with improved integration and earlier use of these agents.
131 total episodes available
Deep-dive analytics for Practice Point Communications
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Practice Point Communications?
<p>WE'VE MOVED!</p><p>Thank you to all our loyal followers. We want to inform you that we have separated our podcast into specific therapeutic area podcasts to hopefully make it easier for you to find the content you're interested in. We now have podcasts for Hematology, Oncology, Pulmonology, Cardiology, HIV, Immunology and Rare Diseases. Just search on Practice Point CME and follow the podcast of your choice.</p><p>Same great content, just easier to find!</p> - How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.